Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Confidence Interval
100%
Kidney Transplantation
100%
HLA Matching
100%
Calcineurin Inhibitor Withdrawal
100%
Adjusted Hazard Ratio
75%
Organ Transplantation
75%
Organ Procurement
75%
Single Center
50%
Thymoglobulin
50%
Kidney Transplant Recipients
50%
Alemtuzumab
50%
Graft Failure Risk
50%
Living Kidney Transplant
50%
Basiliximab
50%
Free Flap Transplantation
50%
Immunosuppression
25%
Acute Rejection
25%
First Year
25%
Registry Data
25%
Low-risk Population
25%
Rejection Rate
25%
Very Low Risk
25%
National Data
25%
Immunology and Microbiology
Organ Transplantation
100%
Kidney Transplantation
100%
Haplotype
100%
Organ Procurement
100%
Anti-Thymocyte Globulin
66%
Alemtuzumab
66%
Basiliximab
66%
Immunosuppression
33%
Acute Graft Rejection
33%
Low Risk Population
33%
Medicine and Dentistry
Organ Transplantation
100%
Kidney Transplantation
100%
Calcineurin Inhibitor
100%
Haplotype
100%
Hazard Ratio
50%
Kidney Graft
50%
Thymocyte Antibody
33%
Graft Failure
33%
Alemtuzumab
33%
Basiliximab
33%
Immunosuppressive Treatment
16%
Acute Graft Rejection
16%
Low Risk Population
16%
Pharmacology, Toxicology and Pharmaceutical Science
Calcineurin Inhibitor
100%
Thymocyte Antibody
66%
Graft Failure
66%
Alemtuzumab
66%
Basiliximab
66%
Acute Graft Rejection
33%